Supernus Pharmaceuticals (SUPN) Debt Ratio (2011 - 2025)

Supernus Pharmaceuticals (SUPN) has 9 years of Debt Ratio data on file, last reported at 0.02 in Q4 2025.

• Debt Ratio for Q4 2025 came in at 0.02, down 38.23% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.02 (down 38.23% YoY), and the FY2025 annual result was 0.02, down 38.23% from the prior year.
• Debt Ratio grew to 0.02 in Q4 2025 per SUPN's latest filing, from 0.01 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.25 in Q4 2021 and troughed at 0.01 in Q3 2025.
• A 5-year average of 0.05 and a median of 0.03 in 2022 frame the typical range for Debt Ratio.
• On a YoY basis, Debt Ratio climbed as much as 1480.6% in 2022 and fell as far as 95.06% in 2022.
• A 5-year view of Debt Ratio shows it stood at 0.25 in 2021, then slumped by 95.06% to 0.01 in 2022, then surged by 228.52% to 0.04 in 2023, then declined by 15.09% to 0.03 in 2024, then plunged by 38.23% to 0.02 in 2025.
• Business Quant data shows SUPN's Debt Ratio at 0.02 in Q4 2025, 0.01 in Q3 2025, and 0.02 in Q1 2025.